



Indications for Electrophysiology Study in children
Seshadri Balaji MBBS, MRCP(UK), PhD
Associate Professor, Department of Pediatrics, Division of Cardiology, Oregon Health & 
Science University, Portland OR USA.
Address for correspondence: Seshadri Balaji MBBS, MRCP(UK), PhD, Associate Professor, 
Department of Pediatrics, Division of Cardiology,  Oregon Health & Science University, 
Portland OR USA. E-mail: balajis/at/ohsu.edu
Key Words: pediatric ablation; electrophysiology; radiofrequency
Introduction
            The advent of electrophysiology (EP) testing revolutionized the care of children with 
arrhythmia. Precise mechanistic and anatomical diagnosis of arrhythmias became possible. The 
later development of catheter-based ablation transformed the care of these children by allowing 
many arrhythmias to be cured during the same procedure. Indications for EP testing vary 
depending on the age of the child, the underlying cardiac anatomy, and the suspected arrhythmia. 
In the current era, the indications for EPS and for ablation are virtually identical. There are a few 
situations where EPS is sometimes performed without the use of ablation, and these will be 
pointed out. This paper will address the common conditions for which EP testing is performed.
Bradycardia
            EP testing is rarely necessary to establish an exact diagnosis in bradycardic patients. 
Non-invasive testing such as Holter monitors, event recorders, and exercise testing are often far 
more helpful because they show the nature of the arrhythmia in the clinical setting.             
            In patients with suspected sinus node disease, if necessary the degree of sinus node 
dysfunction  can be categorized  by testing the response of the sinus node to overdrive 
suppression (the so-called sinus node recovery time). However, it is rare that the same patient 
does not already have demonstrable sinus bradycardia or pauses on a 24 hour ambulatory ECG 
(Holter). Sometimes it can be hard to decide whether sinus bradycardia is secondary to a high 
vagal tone or to an intrinsically abnormal sinus node. In such cases, determination of the sinus 
node recovery time with and without autonomic blockade can help differntiate the two 
conditions. In practice, the need for this is extremely rare.                                                         
            AV node dysfunction can be divided into supra or infra Hissian block. Supra-Hissian 
block shows up on ECG monitoring as Wenckebach while infra-Hissian block shows up as 
Mobitz type 2 block. In the latter group, abnormalities of conduction in either bundle branch are 
often present. In rare patients, His bundle recordings can help determine the exact site of block. 
This can have prognostic implications since infra-Hissian block more often progresses to 
complete block and needs to be treated more aggressively. However, it is rare that EP testing is 
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necessary in order to determine the site of block or the need for pacing.                            
Tachycardia
Supra-ventricular tachycardia                                                                                                             
            Supra-ventricular tachycardia (SVT) is the commonest indication for EPS in children. It 
is the commonest arrhythmia and, with the advent of catheter ablation, is often successfully 
cured during the combined EP/ablation procedure.                                                                       
            Since its initial advent in 1990, catheter ablation results have improved significantly. 
Currently, success rates for simple arrhythmias such as AVNRT is close to 100%, with a very 
low complication rate1. This makes it possible to justify the use of EP procedures in almost 
anyone with diagnosed SVT. However, certain caveats still apply.                                  
            The risk of complications has been shown to be higher in children under the age of 4 
years.   Therefore,   most   authors   [and   the   North   American   Society   for   Pacing   and 
Electrophysiology (NASPE) guidelines in children] apply  higher threshold for performing EP 
procedures in children below 4-5 years1,2.                                                  
            The indications for EP testing and for ablation are almost similar in children with SVT. 
Hence the NASPE guidelines for ablation can be used to also describe the indications for EPS2. 
Perhaps the only two circumstances (with respect to SVT) where EPS is performed without the 
intention of proceeding to ablation are: transesophageal EPS in infants who have SVT resistant 
to medical therapy and sudden death risk assessment in children with asymptomatic WPW.     
            Class I indications are those patients in whom experts in the field agree unequivocally 
that EP testing is beneficial and where there is evidence to prove such a position include the 
following: patients with incessant SVT who show signs of ventricular dysfunction, patients with 
WPW   who   have   had   syncope   or   near-miss   sudden   death,   and   patients   with   VT   and 
hemodynamic  compromise.                                                                                      
            Incessant tachycardia can lead to cardiomyopathy and even death3. Therefore, patients 
with incessant SVT who show ventricular dysfunction are a very serious group. Catheter 
ablation has the potential to completely cure these patients. In children, the commonest 
arrhythmias that lead to cardiomyopathy are: ectopic atrial tachycardia, persistent junctional 
reciprocating tachycardia, and incessant ventricular tachycardia.                                          
            Incessant ectopic atrial tachycardia in infants may be a special category. There is some 
evidence to suggest that if the arrhythmia can be medically controlled, it could resolve 
spontaneously in 2 -3 years4. Therefore, unless the cardiomyopathy is severe, there may be some 
benefit in trying to achieve pharmacologic control in infants.                                  
            The risk of sudden death in WPW has been estimated to be between 1 per 1000 to 10,000 
patient years5. More recent data suggests a higher risk but this is not based on a  population-
based study6. The cause of sudden death is thought to be the development of atrial fibrillation 
(there is an unexplained increase in incidence of AF in WPW patients), which is conducted to 
the ventricle in the presence of an accessory pathway with a short refractory period, leading to 
ventricular fibrillation (VF) and death. The key seems to be the refractory period of the 
accessory pathway being <250 ms. The implication of this is that, any patient with WPW and 
syncope   (or   near-miss   sudden   death)   deserves   and   EP   study   with   ablation7,8.
               Class IIa indications are those where experts have divergent opinions although the 
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majority are in favor of EP testing include: medically refractory SVT in children >4 yrs, children 
with impending CHD surgery who have SVT, children with chronic/incessant SVT without LV 
dysfunction, children with chronic/frequent recurrent incisional atrial reentrant tachycardia 
(IART).  
            Class IIb indications are those where experts hold divergent opinions and there is  no 
majority in favor of the procedure. These are: asymptomatic WPW in children > 5yrs, SVT in 
children > 5 yrs when medications are effective, and SVT in children <5 yrs where medications 
are ineffective or show side effects.                                                                         
            Class III indications are those where there is clear agreement that the procedure is not 
indicated or that risk exceeds benefit. These include: asymptomatic WPW in children < 5yrs, 
SVT in children < 5yrs that is controlled with conventional medications, non sustained VT with 
no LV dysfunction and minimally symptomatic non sustained VT, those with infrequent IART 
episodes, and the use of AVN ablation plus pacer in intractable IART and patients with a single 
episode of VT with hemodynamic compromise that is amenable to ablation.                   
EP for risk stratification of sudden death in CHD patients                                                     
            Risk stratification for the likelihood of sudden death (SD) in patients with CHD has 
remained a problem area. Since the introduction of the implantable cardioverter-defibrillator 
(ICD), there is now hope that SD can be prevented at least in some patients. However, accurate 
risk stratification is essential, since ICD therapy is not without its disadvantages. Some recent 
evidence suggests that EP testing can help. Khairy et al9 reported the results of EP testing in 252 
pts with tetralogy of Fallot  of whom 25% had clinical VT. Monomorphic VT was inducible in 
30% and polymorphic VT in 4.4%. If both forms of VT were combined for the risk stratification 
of sudden death, the sensitivity was 77% and specificity, 80%. The positive predictive value was 
55% and the negative predictive value was 92%. While these percentages are encouraging, much 
work still remains, particularly in other lesions such as transposition and single ventricle.    
Trans-esophageal EPS   in  infants                                                                          
            In some infants, SVT can be hard to control even with potent medications such as the 
class Ic drugs (flecainide, propafenone) and the class III (amiodarone, sotalol). In such instances, 
trans-esophageal EPS with stimulation of the atrium to try and induce SVT can be helpful. 
Failure to induce SVT (while on the drug) by EPS is encouraging and can help the clinician feel 
more confident to allow the baby to go home. Because of the ease with which a TEEPS can be 
performed even at the bedside (using a TEEP catheter passed similar to a naso-gastric tube, a 
portable stimulator and an ECG machine), it can be repeatedly performed until a drug or a 
combination of drugs can be found which lead to successful non-inducibility of the SVT.     
EPS and ablation in CHD patients with SVT and VT                                                       
            Numerous case series have shown the usefulness of ablation to manage SVT and VT in 
patients with CHD10,11. SVT ablations have included patients with IART in complex anatomy 
such as transposition of the great arteries patients with previous Mustard's or Senning's 
operations, or in single ventricle patients who have had the Fontan operation. The latter group is 
widely acknowledged to be the most complex group with the potential for the most difficult 
anatomy, the most complex rhythms and the thickest atriums, which can make ablation 
particularly difficult. Even in these patients, excellent acute success rates have been reported, 
although late recurrence has, so far, remained the main problem10,11.                            
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Conclusions
            EPS has revolutionized our understanding of arrhythmias in children. With the advent of 
ablation, the combination of EPS plus ablation have transformed the care of these children. EPS 
should be considered in every child with a symptomatic arrhythmia and even in some 
asymptomatic ones (such as WPW and incessant arrhythmias) since certain arrhythmias can be 
dangerous to the life or the well being of the child.
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